NEWPORT BEACH, Calif., Feb. 17 /PRNewswire-FirstCall/ -- Nationwide Health Properties, Inc. (NYSE: NHP) today announced results of operations for the fourth quarter and the year ended December 31, 2009. Contemporaneously with this press release, the Company filed its Annual Report on Form 10-K for the fiscal year ended December 31, 2009 with the Securities and Exchange Commission.

"We began 2009 with the capital markets under extreme duress and the recession gripping the U.S. economy. During that difficult period, NHP's primary goals were to fortify its already strong balance sheet and further enhance its liquidity position. These goals were clearly accomplished as evidenced by upgrades to our investment grade rating, leverage-related statistics among the very best for investment grade REITs and over $1 billion of available capital," commented Douglas M. Pasquale, NHP's Chairman and Chief Executive Officer. "For 2010, our strong financial position combined with improvements in the capital markets and the economy has shifted our attention to growth. In February, we acquired two PMB properties for $90 million and improved our multi-year development agreement with them. We expect to close on another five PMB properties before the end of the first quarter" Mr. Pasquale added.

FOURTH QUARTER 2009 RESULTS OF OPERATIONS

The following table presents selected unaudited financial information for the fourth quarter and the year ended December 31, 2009 as compared to the same period of 2008:




                                                                              
                               SELECTED FINANCIAL DATA                        
                      ($ in thousands, except per share amounts)              
                                                                              
                                                                              
                                            Three Months Ended December 31,   
                                            -------------------------------   
                                            2009     2008  $ Change  % Change 
                                            ----     ----  --------  -------- 
                                                                              
    Revenue                              $98,631  $95,894    $2,737       2.9%
    Income from Continuing Operations    $29,675  $31,136   $(1,461)     -4.7%
    Net Income Attributable to NHP Common                                     
         Stockholders                    $30,895  $31,964   $(1,069)     -3.3%
    Net Income Attributable to NHP Common                                     
         Stockholders Per Diluted Share    $0.27    $0.31    $(0.04)    -12.9%
    Diluted FFO                          $61,821  $64,002   $(2,181)     -3.4%
    Adjusted Diluted FFO                 $62,651  $59,361    $3,290       5.5%
    Diluted FFO Per Share                  $0.53    $0.60    $(0.07)    -11.7%
    Adjusted Diluted FFO Per Share         $0.53    $0.56    $(0.03)     -5.4%
    Diluted FAD                          $61,481  $63,195   $(1,714)     -2.7%
    Adjusted Diluted FAD                 $62,311  $58,554    $3,757       6.4%
    Diluted FAD Per Share                  $0.52    $0.59    $(0.07)    -11.9%
    Adjusted Diluted FAD Per Share         $0.53    $0.55    $(0.02)     -3.6%
                                                                              
                                                Year Ended December 31,       
                                                -----------------------       
                                            2009     2008  $ Change  % Change 
                                            ----     ----  --------  -------- 
                                                                              
    Revenue                             $390,512 $368,319   $22,193       6.0%
    Income from Continuing Operations   $125,194 $106,761   $18,433      17.3%
    Net Income Attributable to NHP Common                                     
         Stockholders                   $143,040 $260,501 $(117,461)    -45.1%
    Net Income Attributable to NHP Common                                     
         Stockholders Per Diluted Share    $1.31    $2.63    $(1.32)    -50.2%
    Diluted FFO                         $253,357 $236,514   $16,843       7.1%
    Adjusted Diluted FFO                $249,291 $231,873   $17,418       7.5%
    Diluted FFO Per Share                  $2.27    $2.29    $(0.02)     -0.9%
    Adjusted Diluted FFO Per Share         $2.23    $2.24    $(0.01)     -0.4%
    Diluted FAD                         $251,956 $230,968   $20,988       9.1%
    Adjusted Diluted FAD                $247,890 $226,327   $21,563       9.5%
    Diluted FAD Per Share                  $2.25    $2.23     $0.02       0.9%
    Adjusted Diluted FAD Per Share         $2.22    $2.19     $0.03       1.4%


NON-GAAP FINANCIAL MEASURES

Diluted Funds From Operations ("FFO") and Diluted Funds Available for Distribution ("FAD") are non-GAAP measures that we believe are important to understanding our operations. We believe diluted FFO is an important supplemental measure of operating performance because it excludes the effects of depreciation and amortization and gains (losses) from sales of facilities (both of which are based on historical costs and which may be of limited relevance in evaluating current performance). We believe diluted FAD is an important supplemental measure of operating performance because, like diluted FFO, it excludes the effects of depreciation and amortization and gains (losses) from sales of facilities (both of which are based on historical costs and which may be of limited relevance in evaluating current performance). It also excludes straight-lined rent and other non-cash items that have become more significant for us and our competitors over the last several years. We believe that net income is the most directly comparable GAAP measure to diluted FFO and diluted FAD. Reconciliations between net income and diluted FFO and net income and diluted FAD are included in the accompanying financial data. For guidance, we have also included in the accompanying financial data reconciliations between net income per share and diluted FFO and diluted FAD per share. We have also included adjusted diluted FFO and adjusted diluted FAD amounts which exclude acquisition costs and the recognition of gains on debt extinguishments in 2009.

FOURTH QUARTER 2009 INVESTMENT ACTIVITY

During the fourth quarter of 2009, we sold three facilities for $7.3 million in gross proceeds and we invested approximately $16 million in revenue producing capital expenditures at a blended yield of 8.2% on our existing triple net portfolio.

Pacific Medical Buildings Update

In February of 2010, we acquired the Poway, CA medical office building for $74.0 million and a 71% interest in a joint venture which owns a medical office building in Gilbert, AZ for $6.3 million. Additionally, we committed to loan the joint venture $8.8 million.

We have also signed the amended and restated pipeline agreement whereby Pacific Medical Buildings will be responsible for development and NHP will be responsible for project financing for approved development projects. Other modifications to the development agreement provide NHP with improved terms, including preferred returns, a reduced promote interest to PMB and pricing determined at the time of acquisition rather than at the pre-development stage.

We anticipate acquiring majority interests in joint ventures that own the Mission, Orange, and Pasadena, CA assets and the 55.05% interest in the two San Bernardino, CA assets that we do not already own by the end of the first quarter 2010.

FOURTH QUARTER 2009 FINANCING TRANSACTIONS

During the fourth quarter of 2009, we issued 2.3 million shares of our common stock through our at-the-market equity offering program at an average price of $33.27 per share, resulting in net proceeds of approximately $76.2 million. From January 1, 2010 to February 16, 2010, we issued 635,000 shares of our common stock through our at-the-market equity offering program at an average price of $35.03 per share, resulting in net proceeds of approximately $22.0 million.

On October 1, 2009, we retired $2.6 million of senior notes with an interest rate of 6.90% that were put to us.

During the fourth quarter of 2009, shareholders of our Series B convertible preferred stock converted 235,540 preferred shares into 1,061,195 shares of our common stock. Subsequent to year end, 512,727 shares of Series B preferred stock converted into 2,314,944 shares of our common stock and we redeemed the remaining 917 shares of our Series B convertible preferred stock.

2010 GUIDANCE

Our adjusted diluted FFO guidance per share range is from $2.05 to $2.09 and our adjusted diluted FAD guidance per share range is from $2.01 to $2.05. Our guidance includes shares issued under our at-the-market equity offering program through February 16, 2010 and the Pacific Medical Buildings transactions and excludes any other acquisitions, investments, impairments or capital transactions occurring in 2010. Additionally, certain costs associated with acquisitions which were previously capitalized are now required to be expensed. While our guidance does not assume any acquisitions other than the transactions with Pacific Medical Buildings, we will incur certain costs that will be expensed for any acquisitions we may make and those costs could be material.




      Reconciliation of 2009 Adjusted Diluted FFO to 2010 Adjusted Diluted FFO  
                                    High Guidance                               
                                                                                
                                                             High Guidance    
                                                             -------------    
                                                           Amount   Per Share 
                                                           ------   --------- 
        2009 adjusted diluted FFO                         $249,291      $2.23 
        Internal triple net portfolio growth (1)             5,147       0.05 
        Internal medical office building portfolio growth                       
         (2)                                                  (900)     (0.01)
        Reduction in straight-line rent (3)                 (1,900)     (0.02)
        Leakage and reserves (4)                            (8,750)     (0.08)
        PMB acquisition (5)                                  9,900       0.09 
        Share issuances (6)                                   N/A       (0.17)
                                                             -----      ----- 
        2010 adjusted diluted FFO - high guidance         $252,788      $2.09 
                                                          ========      ===== 

    (1)  Primarily reflects our annual rent escalators
    (2)  Reflects reduction in non-recurring revenue items and renewal/lease-
         up expectations for 2010
    (3)  Reflects the adjustment to rental revenue on our triple net portfolio
         as cash rents received are greater in 2010 than in 2009 and therefore
         the straight line rent adjustment is lower
    (4)  In addition to the ordinary course leakage set forth in our 
         accompanying Supplemental Information Package, reflects reserves for 
         expected lower rent payments compared to 2009 on three unrelated 
         triple net leased facilities 
    (5)  Expected 2010 FFO contribution from the PMB transaction described in 
         this earnings release
    (6)  Dilution resulting from issuance to February 16, 2010 of shares of 
         common stock


CONFERENCE CALL INFORMATION

We have scheduled a conference call and webcast on Thursday, February 18, 2010 at 8:30 a.m. Pacific Time (11:30 a.m. Eastern Time) to discuss these results. The conference call is accessible by dialing 866-271-6130 and referencing conference ID number 46478175 or by logging on to our website at http://www.nhp-reit.com. The international dial-in number is 617-213-8894. The earnings release and any additional financial information that may be discussed on the conference call and webcast will also be available at the same location on our website. A digitized replay of the conference call will be available from 11:30 a.m. Pacific Time (2:30 p.m. Eastern Time) that day until 9:00 p.m. Pacific Time (Midnight Eastern Time) on March 18, 2010. Callers can access the replay by dialing 888-286-8010 or 617-801-6888 and entering conference ID number 31632000. Webcast replays will also be available on our website for at least 12 months following the conference call. Our supplemental information package for the quarter and the year ended December 31, 2009 is available on our website, free of charge, at http://www.nhp-reit.com by selecting "Investor Relations" followed by "Financial Information" and is included in our Current Report on Form 8-K filed February 17, 2010 with the SEC also containing this release. Shareholders may receive free of charge a complete set of our audited financial statements upon request.

ABOUT NATIONWIDE HEALTH PROPERTIES, INC.

Nationwide Health Properties, Inc. is a real estate investment trust (REIT) that invests primarily in healthcare real estate in the United States. As of December 31, 2009, the Company's portfolio of properties, including mortgage loans and properties owned by unconsolidated joint ventures, totaled 576 properties among the following segments: 279 senior housing facilities, 197 skilled nursing facilities, 82 medical office buildings, 11 continuing care retirement communities and 7 specialty hospitals. For more information on Nationwide Health Properties, Inc., visit our website at http://www.nhp-reit.com.

FORWARD LOOKING STATEMENTS

Certain information contained in this release includes forward-looking statements. Forward-looking statements include statements regarding our expectations, beliefs, intentions, plans, objectives, goals, strategies, future events or performance and underlying assumptions and other statements which are not statements of historical facts. These statements may be identified, without limitation, by the use of forward-looking terminology such as "may," "will," "anticipates," "expects," "believes," "intends," "should" or comparable terms or the negative thereof. These forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those described in the statements. Risks and uncertainties associated with our business include (without limitation) the following: deterioration in the operating results or financial condition, including bankruptcies, of our tenants; non-payment or late payment of rent, interest or loan principal amounts by our tenants; our reliance on two tenants for a significant percentage of our revenue; occupancy levels at certain facilities; our level of indebtedness; changes in the ratings of our debt securities; maintaining compliance with our debt covenants; access to the capital markets and the cost and availability of capital; the effect of proposed healthcare reform legislation or government regulations, including changes in the reimbursement levels under the Medicare and Medicaid programs; the general distress of the healthcare industry; increasing competition in our business sector; the effect of economic and market conditions and changes in interest rates; the amount and yield of any additional investments; risks associated with acquisitions, including our ability to identify and complete favorable transactions, delays or failures in obtaining third party consents or approvals, the failure to achieve perceived benefits, unexpected costs or liabilities and potential litigation; the ability of our tenants to pay contractual rent and/or interest escalations in future periods; the ability of our tenants to obtain and maintain adequate liability and other insurance; our ability to attract new tenants for certain facilities; our ability to sell certain facilities for their book value; our ability to retain key personnel; potential liability under environmental laws; the possibility that we could be required to repurchase some of our senior notes; changes in or inadvertent violations of tax laws and regulations and other factors that can affect our status as a real estate investment trust; and other factors discussed from time to time in our news releases, public statements and/or filings with the Securities and Exchange Commission, especially the "Risk Factors" sections of our Annual and Quarterly Reports on Forms 10-K and 10-Q. Forward-looking information is provided by us pursuant to the safe harbor established under the Private Securities Litigation Reform Act of 1995 and should be evaluated in the context of these factors. We disclaim any intent or obligation to update these forward-looking statements.


    Contact:
    --------
    Abdo H. Khoury
    Chief Financial and Portfolio Officer
    Nationwide Health Properties, Inc.
    (949) 718-4400



                     ***Financial Tables to Follow***



                    NATIONWIDE HEALTH PROPERTIES, INC.                
                      CONSOLIDATED INCOME STATEMENTS                  
                   (In thousands, except per share data)              

                                 Three Months Ended    Year Ended     
                                    December 31,       December 31,   
                                  ---------------     -------------   
                                   2009     2008      2009      2008 
                                   ----     ----      ----      ---- 
                                    (Unaudited)                       
    Revenue:                                                          
      Triple-net lease rent      $74,427  $72,115  $295,757  $283,052 
      Medical office building                                         
       operating rent             17,510   17,229    68,319    60,287 
                                  ------   ------    ------    ------ 
                                  91,937   89,344   364,076   343,339 
      Interest and other income    6,694    6,550    26,436    24,980 
                                   -----    -----    ------    ------ 
                                  98,631   95,894   390,512   368,319 
    Expenses:                                                         
      Interest and amortization                                       
       of deferred financing                                          
       costs                      23,091   25,492    93,630   101,045 
      Depreciation and                                                
       amortization               31,804   30,624   124,264   116,375 
      General and administrative   6,928    6,513    27,353    26,051 
      Acquisition costs              830        -       830         - 
      Medical office building                                         
       operating expenses          7,704    7,849    28,906    26,631 
                                   -----    -----    ------    ------ 
                                  70,357   70,478   274,983   270,102 
                                  ------   ------   -------   ------- 
    Operating income              28,274   25,416   115,529    98,217 
      Income from                                                     
       unconsolidated joint                                           
       ventures                    1,401    1,079     5,101     3,903 
      Gain on debt                                                    
       extinguishment, net             -    4,641     4,564     4,641 
                                     ---    -----     -----     ----- 
    Income from continuing                                            
     operations                   29,675   31,136   125,194   106,761 
    Discontinued operations                                           
      Gains on sale of                                                
       facilities, net             2,756    1,552    23,908   154,995 
      (Loss) income from                                              
       discontinued operations       (57)     704       (44)    6,251 
                                     ---      ---       ---     ----- 
                                   2,699    2,256    23,864   161,246 
                                   -----    -----    ------   ------- 
    Net income                    32,374   33,392   149,058   268,007 
      Net (income) loss                                               
       attributable to                                                
       noncontrolling interests     (484)      24      (668)      131 
                                    ----       --      ----       --- 
    Net income attributable to                                        
     NHP                          31,890   33,416   148,390   268,138 
      Preferred stock dividends     (995)  (1,452)   (5,350)   (7,637)
                                    ----   ------    ------    ------ 
    Income available to NHP                                           
     common stockholders         $30,895  $31,964  $143,040  $260,501 
                                 =======  =======  ========  ======== 
                                                                      
    Basic earnings per share (EPS):                                   
      Income from continuing                                          
       operations attributable                                        
       to NHP common                                                  
       stockholders                $0.25    $0.30     $1.11     $1.01 
      Discontinued operations                                         
       attributable to NHP                                            
       common stockholders          0.02     0.02      0.23      1.66 
                                    ----     ----      ----      ---- 
      Net income attributable                                         
       to NHP common                                                  
       stockholders                $0.27    $0.32     $1.34     $2.67 
                                   =====    =====     =====     ===== 
                                                                      
    Diluted EPS:                                                      
      Income from continuing                                          
       operations attributable                                        
       to NHP common                                                  
       stockholders                $0.25    $0.29     $1.09     $1.00 
      Discontinued operations                                         
       attributable to NHP                                            
       common stockholders          0.02     0.02      0.22      1.63 
                                    ----     ----      ----      ---- 
      Net income attributable                                         
       to NHP common                                                  
       stockholders                $0.27    $0.31     $1.31     $2.63 
                                   =====    =====     =====     ===== 
                                                                      
    Weighted average shares
     outstanding for EPS:                      
      Basic                      112,575  100,353   106,329    97,246 
                                 =======  =======   =======    ====== 
      Diluted                    115,009  102,404   108,547    98,763 
                                 =======  =======   =======    ====== 



                        NATIONWIDE HEALTH PROPERTIES, INC.                    
           RECONCILIATIONS OF NET INCOME TO NON-GAAP FINANCIAL MEASURES       
                       (In thousands, except per share data)                  
                                    (Unaudited)                               

               Reconciliation of Net Income to Adjusted Diluted FFO           

                                        Three Months Ended     Year Ended     
                                            December 31,       December 31,   
                                          ---------------     -------------   
                                           2009     2008      2009      2008 
                                           ----     ----      ----      ---- 
    Net income                           $32,374  $33,392  $149,058  $268,007 
      Preferred stock dividends             (995)  (1,452)   (5,350)   (7,637)
      Net (income) loss attributable to                                       
       noncontrolling interests             (484)      24      (668)      131 
      Real estate related depreciation                                        
       and amortization                   31,415   30,837   123,666   118,603 
      Depreciation in income from                                             
       unconsolidated joint ventures       1,272    1,301     5,209     4,768 
      Gains on sale of facilities, net    (2,756)  (1,552)  (23,908) (154,995)
                                          ------   ------   -------  -------- 
    FFO available to NHP common                                               
     stockholders                         60,826   62,550   248,007   228,877 
      Series B preferred dividend add-                                        
       back                                  995    1,452     5,350     7,637 
                                             ---    -----     -----     ----- 
    Diluted FFO                           61,821   64,002   253,357   236,514 
      Acquisition costs                      830        -       830         - 
      Gain on extinguishment of debt,                                         
       net                                     -   (4,641)   (4,564)   (4,641)
      Gain on extinguishment of debt,                                         
       net from unconsolidated joint                                          
       venture                                 -        -      (332)        - 
                                             ---      ---      ----       --- 
    Adjusted diluted FFO                 $62,651  $59,361  $249,291  $231,873 
                                         =======  =======  ========  ======== 
                                                                              
    Weighted average shares outstanding
     for diluted FFO:                      
      Diluted weighted average shares                                         
       outstanding (1)                   115,116  102,455   108,621    98,855 
      Series B preferred stock                                                
       conversion add-back if not                                             
       already converted                   2,517    3,896     3,154     4,526 
                                           -----    -----     -----     ----- 
      Fully diluted weighted average                                          
       shares outstanding                117,633  106,351   111,775   103,381 
                                         =======  =======   =======   ======= 
                                                                              
    Diluted FFO per share                  $0.53    $0.60     $2.27     $2.29 
                                           =====    =====     =====     ===== 
    Adjusted diluted FFO per share         $0.53    $0.56     $2.23     $2.24 
                                           =====    =====     =====     ===== 
                                                                              
    Dividends declared per common share    $0.44    $0.44     $1.76     $1.76 
                                           =====    =====     =====     ===== 
                                                                              
    Adjusted diluted FFO payout ratio         83%      79%       79%       79%
                                             ===      ===       ===       === 
    Adjusted diluted FFO coverage           1.20     1.27      1.27      1.27 
                                            ====     ====      ====      ==== 
                                                                              
    (1) Diluted weighted average shares outstanding includes the effect of all
        participating and non-participating share-based payment awards which 
        for us consists of stock options and other share-based payment awards 
        if the effect is dilutive.  The dilutive effect of all share-based 
        payment awards is calculated using the treasury stock method.  
        Additionally, our redeemable OP units are included as if converted to 
        common stock on a one-for-one basis. 



                        NATIONWIDE HEALTH PROPERTIES, INC.                    
           RECONCILIATIONS OF NET INCOME TO NON-GAAP FINANCIAL MEASURES       
                       (In thousands, except per share data)                  
                                    (Unaudited)                               

               Reconciliation of Net Income to Adjusted Diluted FAD           

                                        Three Months Ended     Year Ended     
                                            December 31,       December 31,   
                                          ---------------     -------------   
                                           2009     2008      2009      2008 
                                           ----     ----      ----      ---- 
    Net income                           $32,374  $33,392  $149,058  $268,007 
      Preferred stock dividends             (995)  (1,452)   (5,350)   (7,637)
      Net (income) loss attributable to                                       
       noncontrolling interests             (484)      24      (668)      131 
      Real estate related depreciation                                        
       and amortization                   31,415   30,837   123,666   118,603 
      Gains on sale of facilities, net    (2,756)  (1,552)  (23,908) (154,995)
      Straight-line rent                  (1,509)  (2,388)   (6,275)  (10,263)
      Amortization of intangible assets                                       
       and liabilities                      (157)    (148)     (564)     (559)
      Non-cash stock-based compensation                                       
       expense                             1,780    1,528     7,007     5,800 
      Deferred finance cost amortization     765      908     3,101     3,173 
      Lease commissions and tenant and                                        
       capital improvements               (1,257)    (716)   (4,733)   (3,715)
      Unconsolidated joint ventures:                                          
        Real estate related                                                   
         depreciation and amortization     1,272    1,301     5,209     4,768 
        Straight-line rent                    17      (12)      (26)      (66)
        Amortization of intangible                                            
         assets and liabilities                -        -         5         - 
        Deferred finance cost                                                 
         amortization                         21       21        84        84 
                                             ---      ---       ---       --- 
    FAD available to NHP common                                               
     stockholders                         60,486   61,743   246,606   223,331 
      Series B preferred dividends           995    1,452     5,350     7,637 
                                             ---    -----     -----     ----- 
    Diluted FAD                           61,481   63,195   251,956   230,968 
      Acquisition costs                      830        -       830         - 
      Gain on extinguishment of debt,                                         
       net                                     -   (4,641)   (4,564)   (4,641)
      Gain on extinguishment of debt,                                         
       net from unconsolidated joint                                          
       venture                                 -        -      (332)        - 
                                             ---      ---      ----       --- 
    Adjusted diluted FAD                 $62,311  $58,554  $247,890  $226,327 
                                         =======  =======  ========  ======== 
                                                                              
    Weighted average shares outstanding
     for diluted FAD:                      
      Diluted weighted average shares                                         
       outstanding (1)                   115,116  102,455   108,621    98,855 
      Series B preferred stock add-back                                       
       if not already converted            2,517    3,896     3,154     4,526 
                                           -----    -----     -----     ----- 
      Fully diluted weighted average                                          
       shares outstanding                117,633  106,351   111,775   103,381 
                                         =======  =======   =======   ======= 
                                                                              
    Diluted FAD per share                  $0.52    $0.59     $2.25     $2.23 
                                           =====    =====     =====     ===== 
    Adjusted diluted FAD per share         $0.53    $0.55     $2.22     $2.19 
                                           =====    =====     =====     ===== 
                                                                              
    Dividends declared per common share    $0.44    $0.44     $1.76     $1.76 
                                           =====    =====     =====     ===== 
                                                                              
    Adjusted diluted FAD payout ratio         83%      80%       79%       80%
                                             ===      ===       ===       === 
    Adjusted diluted FAD coverage           1.20     1.25      1.26      1.24 
                                            ====     ====      ====      ==== 
                                                                              
    (1) Diluted weighted average shares outstanding includes the effect of all
        participating and non-participating share-based payment awards which 
        for us consists of stock options and other share-based payment awards 
        if the effect is dilutive.  The dilutive effect of all share-based 
        payment awards is calculated using the treasury stock method.  
        Additionally, our redeemable OP units are included as if converted to 
        common stock on a one-for-one basis. 



                 NATIONWIDE HEALTH PROPERTIES, INC.             
     RECONCILIATION OF NET INCOME TO NON-GAAP FINANCIAL MEASURES
                (In thousands, except per share data)           

        2010 Guidance Reconciliation of Net Income to Adjusted  
                    Diluted FFO and FAD Per Share               

                                                 Year Ended     
                                              December 31, 2010 
                                             ------------------ 
                                                  Guidance      
                                                  --------      
                                                Low      High   
                                                ---      ----   
                                                                
    Net income                               $152,007  $157,007 
      Preferred stock dividends                   (10)      (10)
      Real estate related depreciation and                      
       amortization                           116,652   116,652 
      Depreciation in income from                               
       unconsolidated joint ventures            4,692     4,692 
      Net income attributable to                                
       noncontrolling interests                (3,695)   (3,695)
      Gains on sales of facilities, net       (22,268)  (22,268)
                                              -------   ------- 
    FFO available to common stockholders      247,378   252,378 
      Series B preferred dividends                 10        10 
                                                  ---       --- 
    Diluted FFO                               247,388   252,388 
      Acquisition costs                           400       400 
                                                  ---       --- 
    Adjusted Diluted FFO                      247,788   252,788 
      Straight-line rent                       (4,074)   (4,074)
      Amortization of intangible assets and                     
       liabilities                               (285)     (285)
      Non-cash stock-based compensation                         
       expense                                  7,026     7,026 
      Deferred finance cost amortization        3,075     3,075 
      Lease commissions and tenant and                          
       capital improvements                   (11,012)  (11,012)
      Unconsolidated Joint Ventures:                            
        Straight-lined rent                        (5)       (5)
        Deferred finance cost amortization         84        84 
                                                  ---       --- 
    Adjusted Diluted FAD                     $242,597  $247,597 
                                             ========  ======== 
                                                                
    Diluted FFO per share                       $2.04     $2.09 
                                                =====     ===== 
    Adjusted Diluted FFO per share              $2.05     $2.09 
                                                =====     ===== 
    Adjusted Diluted FAD per share              $2.01     $2.05 
                                                =====     ===== 
                                                                
    Weighted average shares outstanding:                        
      Diluted weighted average shares                           
       outstanding                            118,869   118,869 
      NHP/PMB OP units                          2,107     2,107 
                                                -----     ----- 
      Total                                   120,976   120,976 
                                              =======   ======= 



                       NATIONWIDE HEALTH PROPERTIES, INC.                   
                           CONSOLIDATED BALANCE SHEETS                      
                                 (In thousands)                             
                                                                            
                                                                            
                                                     December 31, December 31, 
                                                        2009         2008 
                                                        ----         ---- 
    Assets                                                                  
      Investments in real estate:                                           
        Land                                         $318,457      $320,394 
        Buildings and improvements                  3,088,183     3,079,819 
                                                    ---------     --------- 
                                                    3,406,640     3,400,213 
        Less accumulated depreciation                (585,294)     (490,112)
                                                     --------      -------- 
                                                    2,821,346     2,910,101 
        Mortgage loans receivable, net                110,613       112,399 
        Mortgage loan receivable from related                               
         party                                         47,500        47,500 
        Investments in unconsolidated joint                                 
         ventures                                      51,924        54,299 
                                                       ------        ------ 
          Net real estate related investments       3,031,383     3,124,299 
      Cash and cash equivalents                       382,278        82,250 
      Receivables, net                                  6,605         6,066 
      Asset held for sale                                   -         4,542 
      Intangible assets                                93,657       109,434 
      Other assets                                    133,152       131,534 
                                                      -------       ------- 
          Total assets                             $3,647,075    $3,458,125 
                                                   ==========    ========== 
                                                                            
    Liabilities and Equity                                                  
      Unsecured senior credit facility                     $-            $- 
      Senior notes                                    991,633     1,056,233 
      Notes and bonds payable                         431,456       435,199 
      Accounts payable and accrued liabilities        132,915       144,566 
                                                      -------       ------- 
        Total liabilities                           1,556,004     1,635,998 
                                                                            
      Redeemable OP unitholder interests               57,335        56,778 
                                                                            
    Equity:                                                                 
      NHP stockholders' equity                                              
        Series B convertible preferred stock           51,364        74,918 
        Common stock                                   11,432        10,228 
        Capital in excess of par value              2,128,843     1,786,193 
        Cumulative net income                       1,705,279     1,556,889 
        Accumulated other comprehensive (loss)                              
         income                                          (823)        1,846 
        Cumulative dividends                       (1,862,996)   (1,669,407)
                                                   ----------    ---------- 
        Total NHP stockholders' equity              2,033,099     1,760,667 
      Noncontrolling interests                            637         4,682 
                                                          ---         ----- 
        Total equity                                2,033,736     1,765,349 
                                                    ---------     --------- 
          Total liabilities and equity             $3,647,075    $3,458,125 
                                                   ==========    ========== 



SOURCE Nationwide Health Properties, Inc.